What is the recommended dosing of clonidine (antihypertensive medication) for treating flushing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clonidine Dosing for Flushing

For treating flushing, clonidine should be started at 0.1 mg twice daily (morning and bedtime) with gradual titration as needed, typically requiring doses between 0.2-0.6 mg per day. 1

Dosing Recommendations

The FDA-approved dosing guidelines for clonidine provide the foundation for treating flushing:

  • Initial dose: 0.1 mg twice daily (morning and bedtime)
  • Maintenance dose: May increase by 0.1 mg per day at weekly intervals until desired response
  • Typical therapeutic range: 0.2-0.6 mg per day in divided doses
  • Maximum effective daily dose: 2.4 mg (rarely needed) 1

Special Considerations

  • Elderly patients: May benefit from a lower initial dose 1
  • Renal impairment: Start with lower initial dose and monitor carefully 1
  • Administration tip: Taking the larger portion of the daily dose at bedtime may minimize side effects like dry mouth and drowsiness 1

Evidence for Flushing Treatment

Clonidine is one of the few medications specifically studied for flushing conditions:

  • It is currently the only drug available specifically for the treatment of flushing in conditions like rosacea 2
  • For menopausal flushing, studies have shown significant reduction in frequency, severity, and duration of hot flashes:
    • 78% of patients experienced reduced frequency
    • 89% experienced reduced severity
    • 88% experienced reduced duration 3

Dosing for Specific Flushing Conditions

  1. Menopausal flushing:

    • Effective dose range: 0.025-0.075 mg twice daily 4
    • Perimenopausal women may respond to 0.025 mg three times daily
    • Postmenopausal women may require higher doses 5
  2. PTSD-associated flushing/nightmares:

    • Dosage range: 0.2-0.6 mg daily (in divided doses) 6

Monitoring and Side Effects

  • Blood pressure and heart rate: Monitor regularly, especially during initiation and dose adjustments 7
  • Common side effects: Sedation, dry mouth, drowsiness, hypotension, and bradycardia 7
  • Caution: Risk of orthostatic hypotension, particularly when increasing doses

Treatment Algorithm

  1. Start with 0.1 mg twice daily
  2. After 1-2 weeks, assess response:
    • If inadequate response with minimal side effects → increase by 0.1 mg/day
    • If partial response with tolerable side effects → continue current dose for another 1-2 weeks
    • If good response → maintain current dose
  3. Continue weekly adjustments until:
    • Optimal symptom control achieved (typically 0.2-0.6 mg/day)
    • Side effects become intolerable
    • Maximum dose of 2.4 mg/day reached (rarely needed)

Important Caveats

  • Extended-release formulations may provide more stable symptom control with fewer side effects compared to immediate-release formulations, but standard immediate-release is typically used for flushing 7
  • Clonidine may be less effective for rosacea-associated flushing compared to menopausal flushing 8
  • Consider taking the larger portion of the daily dose at bedtime to minimize daytime sedation 1
  • Abrupt discontinuation should be avoided to prevent rebound hypertension

References

Research

The management of rosacea.

American journal of clinical dermatology, 2002

Research

Clonidine (Dixarit) for menopausal flushing.

Canadian Medical Association journal, 1980

Research

Low-dosage clonidine (Dixarit) in menopausal flushing.

The Medical journal of Australia, 1979

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Medication Management for ADHD and PTSD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.